Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A Comparison Between ThinPrep Monolayer and Cytospin Cytology for the Detection of Bladder Cancer.

Kim JY, Kim HJ.

Korean J Urol. 2014 Jun;55(6):390-4. doi: 10.4111/kju.2014.55.6.390. Epub 2014 Jun 16.

2.

Urinary markers for bladder cancer.

Smith ZL, Guzzo TJ.

F1000Prime Rep. 2013 Jul 1;5:21. doi: 10.12703/P5-21. Print 2013.

3.

A pilot study of urinary microRNA as a biomarker for urothelial cancer.

Snowdon J, Boag S, Feilotter H, Izard J, Siemens DR.

Can Urol Assoc J. 2013 Jan-Feb;7(1-2):28-32. doi: 10.5489/cuaj.11115.

4.

The direct anti-cancer effect of a single instillation of epirubicin after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.

Shin YS, Kim JY, Ko OS, Doo AR, Kim MK, Jeong YB, Kim HJ.

Korean J Urol. 2012 Feb;53(2):78-81. doi: 10.4111/kju.2012.53.2.78. Epub 2012 Feb 20.

5.

Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature.

Cauberg Evelyne CC, de la Rosette JJ, de Reijke TM.

Indian J Urol. 2011 Apr;27(2):245-51. doi: 10.4103/0970-1591.82845.

6.

Rationale for an early detection program for bladder cancer.

Khochikar MV.

Indian J Urol. 2011 Apr;27(2):218-25. doi: 10.4103/0970-1591.82841.

7.

The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.

Kwak KW, Kim SH, Lee HM.

J Korean Med Sci. 2009 Dec;24(6):1139-44. doi: 10.3346/jkms.2009.24.6.1139. Epub 2009 Nov 9.

8.

Clinical states model for biomarkers in bladder cancer.

Apolo AB, Milowsky M, Bajorin DF.

Future Oncol. 2009 Sep;5(7):977-92. doi: 10.2217/fon.09.57. Review.

9.

Critical evaluation of urinary markers for bladder cancer detection and monitoring.

Shariat SF, Karam JA, Lotan Y, Karakiewizc PI.

Rev Urol. 2008 Spring;10(2):120-35.

10.

Hyaluronan and hyaluronidase in genitourinary tumors.

Simpson MA, Lokeshwar VB.

Front Biosci. 2008 May 1;13:5664-80. Review.

11.

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.

Knowles MA.

World J Urol. 2007 Dec;25(6):581-93. Epub 2007 Oct 3. Review.

12.

Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI).

Gretzer MB, Partin AW, Chan DW, Veltri RW.

Rev Urol. 2003 Spring;5(2):81-9.

13.

Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.

Fedriga R, Gunelli R, Nanni O, Bacci F, Amadori D, Calistri D.

Neoplasia. 2001 Sep-Oct;3(5):446-50.

Items per page

Supplemental Content

Write to the Help Desk